Table 2. Clinical details of the isolates harbouring NDM gene.
| ID no. | Isolate | Patient age/Sex | Clinical specimen | Ward/OPD/ICU | Current diagnosis | Carbapenem Susceptibility | Other susceptible antibiotics tested in vitro | Coproduction of Class C | NDM or other MBL genes |
|---|---|---|---|---|---|---|---|---|---|
| PA6 | P.aeruginosa | 24year/female | Tissue | Burn | sepsis | R | Polymyxin B | CMY-2 | NDM |
| PA38 | P.aeruginosa | 25 year/female | Central tip | FICU | VAP | R | Polymyxin B | ACT, CMY-2 | NDM |
| PA47 | P.aeruginosa | 29 year/female | Pus | Ortho | sepsis | R | Polymyxin B | DHA, ACT | NDM,IMP, VIM |
OPD, outpatient department; ICU, Intensive care unit; VAP, ventilator-associated pneumonia; FICU, Female intensive care unit R, resistant; Class C-Plasmid mediated AmpC β -lactamases.